News | August 08, 2007

CAD Marks 96 Percent of Cancers Detected with FFDM

August 9, 2007 - Hologic Inc. announced that, according to a recent independent peer-reviewed study published in the July issue of Radiology, computer aided detection correctly marked 99 (96.1 percent) of 103 consecutive asymptomatic breast cancers detected with digital mammographic screening, with an acceptable false marker rate (1.80 false CAD marks per patient). The CAD system (ImageChecker M1000 version 3.1) used in this study was from Hologic’s R2 Technology subsidiary.

Yang and co workers, from the Seoul National University Medical Research Center, reported that the R2 CAD system “marked all 44 breast cancers that manifested as microcalcifications only, all 23 breast cancers that manifested as a mass with microcalcifications and 32 (89 percent) of 36 lesions that appeared as a mass only.” “We are pleased that this study (the first to be published on R2 digital CAD by an independent medical facility) showed such strong results. Of particular note, CAD correctly marked the single invasive lobular carcinoma lesion and 67 of 71 (94.4 percent) of invasive ductal carcinomas, of which 22 had a component of DCIS. As digital mammography gains wider acceptance, R2’s CAD will continue to be a valuable tool to assist radiologists in the earlier detection of breast cancer”, said Dr. Ronald A. Castellino, R2 Technology’s chief medical officer.

Hologic|R2 continues to develop and refine it’s CAD solutions and is currently marketing ImageChecker V8.3 for digital mammography.

For more information: www.r2tech.com and www.hologic.com

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Videos | Artificial Intelligence | December 19, 2017
A post-game roundup by ITN Contributing Editor Greg Freiherr and ITN Editor Dave Fornell on the key trend of artifici
iCAD's PowerLook Tomo Detection Experiences Growing Adoption
News | Mammography | December 14, 2017
December 14, 2017 — iCAD Inc.
Infervision Launches AI Platform to Help Radiologists Diagnose Stroke Faster
Technology | Computed Tomography (CT) | November 28, 2017
Infervision is introducing what it calls the first and only artificial intelligence (AI) platform to help radiologists...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Zebra Medical Vision Collaborating With Google Cloud on AI-Based Imaging Platform
News | Artificial Intelligence | November 09, 2017
Deep learning imaging analytics company Zebra Medical Vision announced that all its current and future radiology...
CureMetrix Expands Medical Advisory Board
News | Computer-Aided Detection Software | November 08, 2017
November 8, 2017 — CureMetrix, a company developing...
PowerLook Tomo Detection Named 2017 New Hampshire High Technology Council Product of the Year
News | Computer-Aided Detection Software | October 27, 2017
iCAD Inc. announced that its PowerLook Tomo Detection has been named 2017 Product of the Year by the New Hampshire High...
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
20/20 GeneSystems Launches AI-Based Lung Cancer Detection Technology in China
Technology | Lung Cancer | August 28, 2017
20/20 GeneSystems Inc. recently released in China what is believed to be the world’s first machine learning algorithm...
Overlay Init